Optimizing Aminoglycoside Use
- 1 January 2011
- journal article
- review article
- Published by Elsevier BV in Critical Care Clinics
- Vol. 27 (1), 107-121
- https://doi.org/10.1016/j.ccc.2010.11.006
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Influence of Empiric Therapy with a β-Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative MicroorganismsAntimicrobial Agents and Chemotherapy, 2010
- Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective AnalysisAntimicrobial Agents and Chemotherapy, 2010
- Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational studyCritical Care, 2010
- Continuous versus Intermittent Infusion of Oxacillin for Treatment of Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2009
- Apoptosis Induced by Aminoglycosides in LLC-PK1 Cells: Comparative Study of Neomycin, Gentamicin, Amikacin, and Isepamicin Using ElectroporationAntimicrobial Agents and Chemotherapy, 2008
- Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement TherapyClinical Pharmacokinetics, 2007
- Mitochondrial 12S rRNA A827G mutation is involved in the genetic susceptibility to aminoglycoside ototoxicityBiochemical and Biophysical Research Communications, 2006
- Gentamicin Causes Apoptosis at Low Concentrations in Renal LLC-PK 1 Cells Subjected to ElectroporationAntimicrobial Agents and Chemotherapy, 2006
- Pharmacodynamics of tobramycin in patients with cystic fibrosisDiagnostic Microbiology and Infectious Disease, 2005
- Aminoglycoside Dosages and NephrotoxicityClinical Pharmacokinetics, 2003